Cell Biotech Co. Ltd (049960) - Total Liabilities

Latest as of September 2025: ₩7.46 Billion KRW ≈ $5.06 Million USD

Based on the latest financial reports, Cell Biotech Co. Ltd (049960) has total liabilities worth ₩7.46 Billion KRW (≈ $5.06 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cell Biotech Co. Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Cell Biotech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 049960 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Cell Biotech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Cell Biotech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
MHC Plantations Bhd KLSE:5026	Malaysia	RM435.98 Million
BEST SPAC I Acquisition Corp. Class A Ordinary Shares NASDAQ:BSAA	USA	$56.30 Million
Tze Shin International Co Ltd TW:2611	Taiwan	NT$1.13 Billion
KG Mobilians Co. Ltd KQ:046440	Korea	₩209.87 Billion
Atrium Real Estate Investment Trust KLSE:5130	Malaysia	RM354.81 Million
Hwa Fong Rubber (Thailand) Public Company Limited BK:HFT	Thailand	฿385.79 Million
JITF Infralogistics Limited NSE:JITFINFRA	India	Rs49.46 Billion
Appeninn Vagyonkezelo Holding Nyilvanosan Mukodo Reszvenytarsasag F:0AP	Germany	€114.90 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Cell Biotech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cell Biotech Co. Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	13.72	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cell Biotech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cell Biotech Co. Ltd (2011–2024)

The table below shows the annual total liabilities of Cell Biotech Co. Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩6.23 Billion ≈ $4.22 Million	+8.23%
2023-12-31	₩5.76 Billion ≈ $3.90 Million	-25.70%
2022-12-31	₩7.75 Billion ≈ $5.25 Million	+25.16%
2021-12-31	₩6.19 Billion ≈ $4.19 Million	+16.42%
2020-12-31	₩5.32 Billion ≈ $3.60 Million	+13.09%
2019-12-31	₩4.70 Billion ≈ $3.19 Million	-26.80%
2018-12-31	₩6.42 Billion ≈ $4.35 Million	+2.26%
2017-12-31	₩6.28 Billion ≈ $4.26 Million	-1.51%
2016-12-31	₩6.38 Billion ≈ $4.32 Million	+2.67%
2015-12-31	₩6.21 Billion ≈ $4.21 Million	+18.44%
2014-12-31	₩5.24 Billion ≈ $3.55 Million	+43.75%
2013-12-31	₩3.65 Billion ≈ $2.47 Million	-6.06%
2012-12-31	₩3.88 Billion ≈ $2.63 Million	-22.03%
2011-12-31	₩4.98 Billion ≈ $3.37 Million	--

About Cell Biotech Co. Ltd

KQ:049960 Korea Biotechnology & Medical Research

Market Cap

$83.34 Million

₩122.98 Billion KRW

Market Cap Rank

#19973 Global

#1050 in Korea

Share Price

₩15930.00

Change (1 day)

-1.97%

52-Week Range

₩11500.00 - ₩18110.00

All Time High

₩56579.38